{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:28:13Z","timestamp":1779114493820,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,18]]},"DOI":"10.7759\/cureus.109107","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:31:43Z","timestamp":1779111103000},"source":"Crossref","is-referenced-by-count":0,"title":["Adiponectin\u2019s Role in the Development and Progression of Differentiated Thyroid Carcinoma: A Narrative Review of Current Evidence"],"prefix":"10.7759","author":[{"given":"Ruxandra","family":"Daniealopol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Daniealopol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Daniela","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radu","family":"Neagoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Differentiated thyroid carcinoma","author":"Gimm O","year":"2001","unstructured":"Gimm O, Dralle H. Differentiated thyroid carcinoma. Surgical Treatment: Evidence-Based and Problem-Oriented. Holzheimer RG, Mannick JA (ed):  Zuckschwerdt, Munich; 2001. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK6979\/:"},{"key":"ref2","unstructured":"American Thyroid Association. Thyroid cancer (papillary and follicular). Accessed: April 25, 2026: https:\/\/www.thyroid.org\/cancer-of-the-thyroid\/."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-025-01168-y","article-title":"Unravelling the rise in thyroid cancer incidence and addressing overdiagnosis","volume":"22","author":"Chen DW","year":"2026","unstructured":"Chen DW, Haymart MR. Unravelling the rise in thyroid cancer incidence and addressing overdiagnosis. Nat Rev Endocrinol. 2026, 22:10-20. 10.1038\/s41574-025-01168-y","journal-title":"Nat Rev Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00672-8","article-title":"Is early-onset cancer an emerging global epidemic? Current evidence and future implications","volume":"19","author":"Ugai T","year":"2022","unstructured":"Ugai T, Sasamoto N, Lee HY, et al.. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022, 19:656-73. 10.1038\/s41571-022-00672-8","journal-title":"Nat Rev Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31172","article-title":"Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: the EPIC study","volume":"142","author":"Dossus L","year":"2018","unstructured":"Dossus L, Franceschi S, Biessy C, et al.. Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: the EPIC study. Int J Cancer. 2018, 142:1332-42. 10.1002\/ijc.31172","journal-title":"Int J Cancer"},{"key":"ref6","unstructured":"World Health Organization. Obesity. Accessed: April 25, 2026: https:\/\/www.who.int\/health-topics\/obesity#tab=tab_1."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2025.07.007","article-title":"Obesity-driven inflammation and cancer risk: a comprehensive review","volume":"114","author":"Lamabadusuriya DA","year":"2025","unstructured":"Lamabadusuriya DA, Jayasena H, Bopitiya AK, De Silva AD, Jayasekera P. Obesity-driven inflammation and cancer risk: a comprehensive review. Semin Cancer Biol. 2025, 114:256-66. 10.1016\/j.semcancer.2025.07.007","journal-title":"Semin Cancer Biol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-014-0124-9","article-title":"Low-grade inflammation, obesity, and diabetes","volume":"3","author":"Pereira SS","year":"2014","unstructured":"Pereira SS, Alvarez-Leite JI. Low-grade inflammation, obesity, and diabetes. Curr Obes Rep. 2014, 3:422-31. 10.1007\/s13679-014-0124-9","journal-title":"Curr Obes Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2018.11.001","article-title":"Obesity and cancer risk: emerging biological mechanisms and perspectives","volume":"92","author":"Avgerinos KI","year":"2019","unstructured":"Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019, 92:121-35. 10.1016\/j.metabol.2018.11.001","journal-title":"Metabolism"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/osp4.70113","article-title":"Recent insights into circulating adipokines in obesity: systematic review and meta-analysis","volume":"12","author":"Sunita S","year":"2026","unstructured":"Sunita S, Ghozali M, Rizki Akbar M, et al.. Recent insights into circulating adipokines in obesity: systematic review and meta-analysis. Obes Sci Pract. 2026, 12:e70113. 10.1002\/osp4.70113","journal-title":"Obes Sci Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12997","article-title":"Adipokine dysregulation and adipose tissue inflammation in human obesity","volume":"48","author":"Unamuno X","year":"2018","unstructured":"Unamuno X, G\u00f3mez-Ambrosi J, Rodr\u00edguez A, Becerril S, Fr\u00fchbeck G, Catal\u00e1n V. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest. 2018, 48:e12997. 10.1111\/eci.12997","journal-title":"Eur J Clin Invest"},{"key":"ref12","article-title":"Chapter five - adiponectin and its isoforms in pathophysiology","volume":"85","author":"van Andel M","year":"2018","unstructured":"van Andel M, Heijboer AC, Drent ML. Chapter five - adiponectin and its isoforms in pathophysiology. Adv Clin Chem. 2018, 85:115-47.","journal-title":"Adv Clin Chem"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-48382-5_18","article-title":"Adiponectin-resistance in obesity","author":"Engin A","year":"2017","unstructured":"Engin A. Adiponectin-resistance in obesity. Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology. Engin A, Engin A (ed): Springer, Cham; 2017. 960:415-41. 10.1007\/978-3-319-48382-5_18"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-63657-8_15","article-title":"Adiponectin resistance in obesity: adiponectin leptin\/insulin interaction","volume":"1460","author":"Engin A","year":"2024","unstructured":"Engin A. Adiponectin resistance in obesity: adiponectin leptin\/insulin interaction. Adv Exp Med Biol. 2024, 1460:431-62. 10.1007\/978-3-031-63657-8_15","journal-title":"Adv Exp Med Biol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.12.016","article-title":"Updates on \"adiponcosis\": more new incoming evidence strengthening the obesity-cancer link","volume":"41","author":"Bifulco M","year":"2017","unstructured":"Bifulco M, Ciaglia E. Updates on \"adiponcosis\": more new incoming evidence strengthening the obesity-cancer link. Eur J Intern Med. 2017, 41:e19-20. 10.1016\/j.ejim.2016.12.016","journal-title":"Eur J Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040839","article-title":"Adiponectin as link factor between adipose tissue and cancer","volume":"20","author":"Di Zazzo E","year":"2019","unstructured":"Di Zazzo E, Polito R, Bartollino S, et al.. Adiponectin as link factor between adipose tissue and cancer. Int J Mol Sci. 2019, 20:839. 10.3390\/ijms20040839","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2020.0919","article-title":"Adiponectin and thyroid cancer: insight into the association between adiponectin and obesity","volume":"12","author":"Zhou Y","year":"2021","unstructured":"Zhou Y, Yang Y, Zhou T, Li B, Wang Z. Adiponectin and thyroid cancer: insight into the association between adiponectin and obesity. Aging Dis. 2021, 12:597-613. 10.14336\/AD.2020.0919","journal-title":"Aging Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/biom15060820","article-title":"Unravelling the adiponectin hallmark and exploring the therapeutic potential of its receptor agonists in cancer metabolic reprogramming","volume":"15","author":"Kafeel S","year":"2025","unstructured":"Kafeel S, Palmiero G, Salzillo A, Ragone A, Naviglio S, Sapio L. Unravelling the adiponectin hallmark and exploring the therapeutic potential of its receptor agonists in cancer metabolic reprogramming. Biomolecules. 2025, 15:820. 10.3390\/biom15060820","journal-title":"Biomolecules"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/nu13041180","article-title":"Adiponectin: structure, physiological functions, role in diseases, and effects of nutrition","volume":"13","author":"Khoramipour K","year":"2021","unstructured":"Khoramipour K, Chamari K, Hekmatikar AA, Ziyaiyan A, Taherkhani S, Elguindy NM, Bragazzi NL. Adiponectin: structure, physiological functions, role in diseases, and effects of nutrition. Nutrients. 2021, 13:1180. 10.3390\/nu13041180","journal-title":"Nutrients"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.454835","article-title":"T-cadherin is essential for adiponectin-mediated revascularization","volume":"288","author":"Parker-Duffen JL","year":"2013","unstructured":"Parker-Duffen JL, Nakamura K, Silver M, et al.. T-cadherin is essential for adiponectin-mediated revascularization. J Biol Chem. 2013, 288:24886-97. 10.1074\/jbc.M113.454835","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.010970","article-title":"Mapping and engineering the interaction between adiponectin and T-cadherin","volume":"295","author":"Pascolutti R","year":"2020","unstructured":"Pascolutti R, Erlandson SC, Burri DJ, Zheng S, Kruse AC. Mapping and engineering the interaction between adiponectin and T-cadherin. J Biol Chem. 2020, 295:2749-59. 10.1074\/jbc.RA119.010970","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.404624","article-title":"Adiponectin receptors form homomers and heteromers exhibiting distinct ligand binding and intracellular signaling properties","volume":"288","author":"Almabouada F","year":"2013","unstructured":"Almabouada F, Diaz-Ruiz A, Rabanal-Ruiz Y, Peinado JR, Vazquez-Martinez R, Malagon MM. Adiponectin receptors form homomers and heteromers exhibiting distinct ligand binding and intracellular signaling properties. J Biol Chem. 2013, 288:3112-25. 10.1074\/jbc.M112.404624","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2009.11.004","article-title":"Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma","volume":"147","author":"Cheng SP","year":"2010","unstructured":"Cheng SP, Chi CW, Tzen CY, Yang TL, Lee JJ, Liu TP, Liu CL. Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery. 2010, 147:847-53. 10.1016\/j.surg.2009.11.004","journal-title":"Surgery"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1908","article-title":"Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies","volume":"96","author":"Mitsiades N","year":"2011","unstructured":"Mitsiades N, Pazaitou-Panayiotou K, Aronis KN, et al.. Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies. J Clin Endocrinol Metab. 2011, 96:E2023-8. 10.1210\/jc.2010-1908","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-013-1570-5","article-title":"AdipoR1 and AdipoR2 gene expression are regulated by thyroid hormones in adipose tissue","volume":"377","author":"Seifi S","year":"2013","unstructured":"Seifi S, Nazifi S, Tabandeh MR, Saeb M. AdipoR1 and AdipoR2 gene expression are regulated by thyroid hormones in adipose tissue. Mol Cell Biochem. 2013, 377:55-63. 10.1007\/s11010-013-1570-5","journal-title":"Mol Cell Biochem"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence","volume":"33","author":"Dalamaga M","year":"2012","unstructured":"Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012, 33:547-94. 10.1210\/er.2011-1015","journal-title":"Endocr Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102519","article-title":"Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease","volume":"20","author":"Parida S","year":"2019","unstructured":"Parida S, Siddharth S, Sharma D. Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease. Int J Mol Sci. 2019, 20:2519. 10.3390\/ijms20102519","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2011.03.007","article-title":"Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma","volume":"15","author":"Siddique A","year":"2011","unstructured":"Siddique A, Kowdley KV. Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma. Clin Liver Dis. 2011, 15:281-96. 10.1016\/j.cld.2011.03.007","journal-title":"Clin Liver Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12141","article-title":"IGF bioregulation system in benign and malignant thyroid nodular disease: a systematic review","volume":"34","author":"Karagiannis A","year":"2020","unstructured":"Karagiannis A, Kassi E, Chatzigeorgiou A, Koutsilieris M. IGF bioregulation system in benign and malignant thyroid nodular disease: a systematic review. In Vivo. 2020, 34:3069-91. 10.21873\/invivo.12141","journal-title":"In Vivo"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-019-0142-5","article-title":"Adiponectin: the \"unusual suspect\" between insulin resistance and cancer?","volume":"22","author":"Michalakis K","year":"2019","unstructured":"Michalakis K. Adiponectin: the \"unusual suspect\" between insulin resistance and cancer?. Prostate Cancer Prostatic Dis. 2019, 22:636-7. 10.1038\/s41391-019-0142-5","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4158\/EP15814.OR","article-title":"Serum adiponectin and insulin-like growth factor 1 in predominantly female patients with thyroid cancer: association with the histologic characteristics of the tumor","volume":"22","author":"Pazaitou-Panayiotou K","year":"2016","unstructured":"Pazaitou-Panayiotou K, Panagiotou G, Polyzos SA, Mantzoros CS. Serum adiponectin and insulin-like growth factor 1 in predominantly female patients with thyroid cancer: association with the histologic characteristics of the tumor. Endocr Pract. 2016, 22:68-75. 10.4158\/EP15814.OR","journal-title":"Endocr Pract"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-012-9419-1","article-title":"Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma","volume":"65","author":"Cheng SP","year":"2013","unstructured":"Cheng SP, Liu CL, Hsu YC, Chang YC, Huang SY, Lee JJ. Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma. Cell Biochem Biophys. 2013, 65:203-10. 10.1007\/s12013-012-9419-1","journal-title":"Cell Biochem Biophys"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19031116","article-title":"Obesity and thyroid cancer risk: an update","volume":"19","author":"Franchini F","year":"2022","unstructured":"Franchini F, Palatucci G, Colao A, Ungaro P, Macchia PE, Nettore IC. Obesity and thyroid cancer risk: an update. Int J Environ Res Public Health. 2022, 19:1116. 10.3390\/ijerph19031116","journal-title":"Int J Environ Res Public Health"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07299-x","article-title":"Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies","volume":"20","author":"Zhao J","year":"2020","unstructured":"Zhao J, Wen J, Wang S, Yao J, Liao L, Dong J. Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies. BMC Cancer. 2020, 20:788. 10.1186\/s12885-020-07299-x","journal-title":"BMC Cancer"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2020.35.2.396","article-title":"Serum adiponectin and progranulin level in patients with benign thyroid nodule or papillary thyroid cancer","volume":"35","author":"Kwon H","year":"2020","unstructured":"Kwon H, Park SE, Yun JS, Park CY. Serum adiponectin and progranulin level in patients with benign thyroid nodule or papillary thyroid cancer. Endocrinol Metab. 2020, 35:396-406. 10.3803\/EnM.2020.35.2.396","journal-title":"Endocrinol Metab"},{"key":"ref36","article-title":"Lack of association between serum adiponectin\/leptin levels and medullary thyroid cancer","volume":"17","author":"Abooshahab R","year":"2016","unstructured":"Abooshahab R, Yaghmaei P, Ghadaksaz HG, Hedayati M. Lack of association between serum adiponectin\/leptin levels and medullary thyroid cancer. Asian Pac J Cancer Prev. 2016, 17:3861-4.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0262","article-title":"Circulating adipokines and metabolic setting in differentiated thyroid cancer","volume":"8","author":"Mele C","year":"2019","unstructured":"Mele C, Sam\u00e0 MT, Bisoffi AA, et al.. Circulating adipokines and metabolic setting in differentiated thyroid cancer. Endocr Connect. 2019, 8:997-1006. 10.1530\/EC-19-0262","journal-title":"Endocr Connect"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1089\/met.2012.0065","article-title":"Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study","volume":"11","author":"Gardener H","year":"2013","unstructured":"Gardener H, Crisby M, Sjoberg C, et al.. Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study. Metab Syndr Relat Disord. 2013, 11:46-55. 10.1089\/met.2012.0065","journal-title":"Metab Syndr Relat Disord"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4921803","article-title":"Concentrations of selected adipokines, interleukin-6, and vitamin D in patients with papillary thyroid carcinoma in respect to thyroid cancer stages","volume":"2018","author":"Warakomski J","year":"2018","unstructured":"Warakomski J, Romuk E, Jarz\u0105b B, Krajewska J, Siemi\u0144ska L. Concentrations of selected adipokines, interleukin-6, and vitamin D in patients with papillary thyroid carcinoma in respect to thyroid cancer stages. Int J Endocrinol. 2018, 2018:4921803. 10.1155\/2018\/4921803","journal-title":"Int J Endocrinol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqae030","article-title":"Adiponectin inhibits the progression of obesity-associated papillary thyroid carcinoma through autophagy","volume":"165","author":"Li C","year":"2024","unstructured":"Li C, Zhang J, Dionigi G, Liang N, Guan H, Sun H. Adiponectin inhibits the progression of obesity-associated papillary thyroid carcinoma through autophagy. Endocrinology. 2024, 165:bqae030. 10.1210\/endocr\/bqae030","journal-title":"Endocrinology"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0930","article-title":"Molecular pathways: adiponectin and leptin signaling in cancer","volume":"19","author":"Vansaun MN","year":"2013","unstructured":"Vansaun MN. Molecular pathways: adiponectin and leptin signaling in cancer. Clin Cancer Res. 2013, 19:1926-32. 10.1158\/1078-0432.CCR-12-0930","journal-title":"Clin Cancer Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki T","year":"2006","unstructured":"Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006, 116:1784-92. 10.1172\/JCI29126","journal-title":"J Clin Invest"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2009.28449C","article-title":"Adiponectin in insulin resistance: lessons from translational research","volume":"91","author":"Ziemke F","year":"2010","unstructured":"Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010, 91:258S-61S. 10.3945\/ajcn.2009.28449C","journal-title":"Am J Clin Nutr"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154325","article-title":"S100A6 promotes the development of thyroid cancer and inhibits apoptosis of thyroid cancer cells through the PI3K\/AKT\/mTOR pathway","volume":"242","author":"Chen B","year":"2023","unstructured":"Chen B, Zheng D, Liu C, et al.. S100A6 promotes the development of thyroid cancer and inhibits apoptosis of thyroid cancer cells through the PI3K\/AKT\/mTOR pathway. Pathol Res Pract. 2023, 242:154325. 10.1016\/j.prp.2023.154325","journal-title":"Pathol Res Pract"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.152950","article-title":"Knockout of ASAP1 induces autophagy in papillary thyroid carcinoma by inhibiting the mTOR signaling pathway","volume":"216","author":"Jiang N","year":"2020","unstructured":"Jiang N, Yang Y, Zhao G, et al.. Knockout of ASAP1 induces autophagy in papillary thyroid carcinoma by inhibiting the mTOR signaling pathway. Pathol Res Pract. 2020, 216:152950. 10.1016\/j.prp.2020.152950","journal-title":"Pathol Res Pract"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102483","article-title":"Metformin as a promising therapeutic agent for papillary thyroid cancer: mechanisms of antitumor and pro-apoptotic activity","volume":"60","author":"Wincenciuk K","year":"2025","unstructured":"Wincenciuk K, Buczy\u0144ska A, Kr\u0119towski AJ, Adamska A. Metformin as a promising therapeutic agent for papillary thyroid cancer: mechanisms of antitumor and pro-apoptotic activity. Transl Oncol. 2025, 60:102483. 10.1016\/j.tranon.2025.102483","journal-title":"Transl Oncol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1080\/20565623.2025.2580889","article-title":"Mechanisms and pathways of ROS and autophagy in thyroid cancer","volume":"11","author":"Wu J","year":"2025","unstructured":"Wu J, Chen Z, Duan J, Zhang G. Mechanisms and pathways of ROS and autophagy in thyroid cancer. Future Sci OA. 2025, 11:2580889. 10.1080\/20565623.2025.2580889","journal-title":"Future Sci OA"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04265-6","article-title":"The new insights into autophagy in thyroid cancer progression","volume":"21","author":"Shi YB","year":"2023","unstructured":"Shi YB, Chen SY, Liu RB. The new insights into autophagy in thyroid cancer progression. J Transl Med. 2023, 21:413. 10.1186\/s12967-023-04265-6","journal-title":"J Transl Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.821855","article-title":"Targeting autophagy in thyroid cancer: EMT, apoptosis, and cancer stem cells","volume":"10","author":"Holm TM","year":"2022","unstructured":"Holm TM, Yeo S, Turner KM, Guan JL. Targeting autophagy in thyroid cancer: EMT, apoptosis, and cancer stem cells. Front Cell Dev Biol. 2022, 10:821855. 10.3389\/fcell.2022.821855","journal-title":"Front Cell Dev Biol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/291546","article-title":"Obesity as a major risk factor for cancer","volume":"2013","author":"De Pergola G","year":"2013","unstructured":"De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013, 2013:291546. 10.1155\/2013\/291546","journal-title":"J Obes"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115569","article-title":"AdipoRon and other adiponectin receptor agonists as potential candidates in cancer treatments","volume":"22","author":"Nigro E","year":"2021","unstructured":"Nigro E, Daniele A, Salzillo A, Ragone A, Naviglio S, Sapio L. AdipoRon and other adiponectin receptor agonists as potential candidates in cancer treatments. Int J Mol Sci. 2021, 22:5569. 10.3390\/ijms22115569","journal-title":"Int J Mol Sci"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02792-z","article-title":"Exploring the logic and conducting a comprehensive evaluation of AdipoRon-based adiponectin replacement therapy against hormone-related cancers-a systematic review","volume":"397","author":"Laurindo LF","year":"2024","unstructured":"Laurindo LF, Sosin AF, Lamas CB, de Alvares Goulart R, Dos Santos Haber JF, Detregiachi CR, Barbalho SM. Exploring the logic and conducting a comprehensive evaluation of AdipoRon-based adiponectin replacement therapy against hormone-related cancers-a systematic review. Naunyn Schmiedebergs Arch Pharmacol. 2024, 397:2067-82. 10.1007\/s00210-023-02792-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0851-z","article-title":"Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1\/ERK-dependent necroptosis","volume":"9","author":"Akimoto M","year":"2018","unstructured":"Akimoto M, Maruyama R, Kawabata Y, Tajima Y, Takenaga K. Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1\/ERK-dependent necroptosis. Cell Death Dis. 2018, 9:804. 10.1038\/s41419-018-0851-z","journal-title":"Cell Death Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/486257-adiponectins-role-in-the-development-and-progression-of-differentiated-thyroid-carcinoma-a-narrative-review-of-current-evidence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:31:46Z","timestamp":1779111106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/486257-adiponectins-role-in-the-development-and-progression-of-differentiated-thyroid-carcinoma-a-narrative-review-of-current-evidence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.109107","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,18]]}}}